US Stock MarketDetailed Quotes
FRTX FRESH TRACKS THERAPEUTICS INC
- 0.720
- +0.005+0.70%
15min DelayClose Nov 25 14:39 ET
4.30MMarket Cap-679P/E (TTM)
0.720High0.720Low1.27KVolume0.720Open0.715Pre Close917.28Turnover0.03%Turnover RatioLossP/E (Static)5.97MShares1.03352wk High0.43P/B3.57MFloat Cap0.55052wk Low--Dividend TTM4.96MShs Float23152.500Historical High--Div YieldTTM0.00%Amplitude0.450Historical Low0.720Avg Price1Lot Size
About FRESH TRACKS THERAPEUTICS INC Company
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in September 2009 and is headquartered in Boulder, CO.
Company Profile
SymbolFRTX
Company NameFRESH TRACKS THERAPEUTICS INC
Listing DateMar 9, 1993
Founded2009
CEOMr. Albert N. Marchio
MarketPink Market
Employees4
Fiscal Year Ends12-31
Address5777 Central Avenue,Suite 102
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-720-505-4755
Websitehttp://www.frtx.com
Company Executives
- Name
- Position
- Salary
- Albert N. Marchio
- Chairman of the Board, Chief Executive Officer, Chief Financial Officer, and Secretary
- --
- David R. McAvoy
- General Counsel and Chief Compliance Officer
- --
- Aaron Fox-Collis
- Vice President of Finance and Chief Accounting Officer
- --
- Deepak Chadha
- Chief Research and Development Officer and Chief Operating Officer
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data